glp 1 agonist eye side effects Adverse of GLP-1 class drugs. Gastrointestinal issues are GI Adverse Effects of Glucagon-Like
Description
doi: 10.2337/dc12-2006 77 RosenstockJRaccahDKornyiLMaffeiLBokaGMiossecPet al
It is the first triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, a mechanism that produced 24.2% mean body weight reduction in Phase 2 trials and a staggering 28.7% in Phase 3 data
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
Weight Management The GLP-1-like properties of allulose extend to appetite regulation and weight management
16-18 Nausea is the most frequently reported AE among GLP-1 RAs, with rates ranging from 20% to 40% depending on the agent and dose
2023 Apr 6;18(4):e0281150
